According to Global Times, the five pharmaceutical companies are Zhejiang Huahai Pharmaceutical Co, Apeloa Pharmaceutical, Fosun Pharma, Zhejiang Jiuzhou Pharmaceutical Co and Shanghai Desano Pharmaceuticals Co. They sealed the agreement with Medicines Patent Pool.
Of the five companies, Zhejiang Jiuzhou Pharmaceutical Co will focus on producing the drug substance and the other four will produce the finished product.
The medicine will be supplied in 95 low- and middle-income nations, comprising 53 percent of the world’s population.
pgh/iff/oda/ymr
